VASCULAR BIOGENICS LTD's ticker is and the CUSIP is M96883909. A total of 4 filers reported holding VASCULAR BIOGENICS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $20,000 | -42.9% | 12,600 | -39.4% | 0.00% | – |
| Q1 2022 | $35,000 | -69.8% | 20,800 | -64.7% | 0.00% | – |
| Q4 2021 | $116,000 | -15.9% | 58,900 | -12.4% | 0.00% | – |
| Q3 2021 | $138,000 | +91.7% | 67,200 | +121.8% | 0.00% | – |
| Q2 2021 | $72,000 | +111.8% | 30,300 | +80.4% | 0.00% | – |
| Q1 2021 | $34,000 | -73.2% | 16,800 | +330.8% | 0.00% | – |
| Q3 2020 | $127,000 | +4133.3% | 3,900 | +95.0% | 0.00% | – |
| Q3 2019 | $3,000 | -88.0% | 2,000 | -82.3% | 0.00% | – |
| Q2 2018 | $25,000 | -56.1% | 11,300 | -54.4% | 0.00% | -100.0% |
| Q1 2018 | $57,000 | +46.2% | 24,800 | +350.9% | 0.00% | – |
| Q4 2017 | $39,000 | -70.5% | 5,500 | -74.7% | 0.00% | -100.0% |
| Q3 2017 | $132,000 | +1785.7% | 21,700 | +1569.2% | 0.00% | – |
| Q1 2017 | $7,000 | +40.0% | 1,300 | +30.0% | 0.00% | – |
| Q2 2016 | $5,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 198 | $41,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 67,200 | $138,000 | 0.00% |
| SIMPLEX TRADING, LLC | 52,800 | $122,000 | 0.00% |